Product Images Enoxaparin Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 32 images provide visual information about the product associated with Enoxaparin Sodium NDC 63323-605 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure A - Enox FK Nova 01

Figure A - Enox FK Nova 01

Figure B - Enox FK Nova 02

Figure B - Enox FK Nova 02

Figure C - Enox FK Nova 03

Figure C - Enox FK Nova 03

Figure D - Enox FK Nova 04

Figure D - Enox FK Nova 04

Figure E - Enox FK Nova 05

Figure E - Enox FK Nova 05

Chemical Structure - Enox FK Nova 06

Chemical Structure - Enox FK Nova 06

Chemical Structure - Enox FK Nova 07

Chemical Structure - Enox FK Nova 07

Figure 1 - Enox FK Nova 08

Figure 1 - Enox FK Nova 08

Figure 2 - Enox FK Nova 09

Figure 2 - Enox FK Nova 09

PRINCIPAL DISPLAY PANEL - 30 mg/0.3 mL Syringe Carton - Enox FK Nova 10

PRINCIPAL DISPLAY PANEL - 30 mg/0.3 mL Syringe Carton - Enox FK Nova 10

PRINCIPAL DISPLAY PANEL - 40 mg/0.4 mL Syringe Carton - Enox FK Nova 11

PRINCIPAL DISPLAY PANEL - 40 mg/0.4 mL Syringe Carton - Enox FK Nova 11

PRINCIPAL DISPLAY PANEL - 60 mg/0.6 mL Syringe Carton - Enox FK Nova 12

PRINCIPAL DISPLAY PANEL - 60 mg/0.6 mL Syringe Carton - Enox FK Nova 12

PRINCIPAL DISPLAY PANEL - 80 mg/0.8 mL Syringe Carton - Enox FK Nova 13

PRINCIPAL DISPLAY PANEL - 80 mg/0.8 mL Syringe Carton - Enox FK Nova 13

PRINCIPAL DISPLAY PANEL - 100 mg/1 mL Syringe Carton - Enox FK Nova 14

PRINCIPAL DISPLAY PANEL - 100 mg/1 mL Syringe Carton - Enox FK Nova 14

PRINCIPAL DISPLAY PANEL - 300 mg/3 mL Vial Carton - Enox FK Nova 15

PRINCIPAL DISPLAY PANEL - 300 mg/3 mL Vial Carton - Enox FK Nova 15

PRINCIPAL DISPLAY PANEL - 120 mg/0.8 mL Syringe Carton - Enox FK Nova 16

PRINCIPAL DISPLAY PANEL - 120 mg/0.8 mL Syringe Carton - Enox FK Nova 16

PRINCIPAL DISPLAY PANEL - 150 mg/1 mL Syringe Carton - Enox FK Nova 17

PRINCIPAL DISPLAY PANEL - 150 mg/1 mL Syringe Carton - Enox FK Nova 17

Enox FK Nova 18

Enox FK Nova 18

Enox FK Nova 19

Enox FK Nova 19

Enox FK Nova 20

Enox FK Nova 20

Enox FK Nova 21

Enox FK Nova 21

Enox FK Nova 22

Enox FK Nova 22

Enox FK Nova 23

Enox FK Nova 23

Enox FK Nova 24

Enox FK Nova 24

Enox FK Nova 25

Enox FK Nova 25

This is a description of Enoxaparin Sodium Injection, which is for subcutaneous injection only. The package contains ten single dose syringes with automatic safety devices, each containing 30mg of Enoxaparin Sodium derived from porcine intestinal mucosa in water for injection. The dosage and administration are explained in the package insert. The syringe comes with direction on how to remove the needle shield, adjust the dose, and activate the safety device before injecting. The safety system can only be activated once the needle is emptied, and the needle shield must not be replaced after injection.*

Enox FK Nova 26

Enox FK Nova 26

Enoxaparin Sodium Injection is a medication available in the form of single dose syringes with an automatic safety device, used for subcutaneous injection. It is manufactured by Fresenlus Kabl USA, LLC with registered trademarks of Novation, LLC. The syringes contain enoxaparin sodium (40mg/mL) derived from porcine intestinal mucosa in Water for Injection. The package insert contains information about dosage and administration. The medication should be stored at 25°C with permitted excursions to 15-30°C, and kept away from children. The text contains directions for the use of single dose syringes with automatic safety devices.*

Enox FK Nova 27

Enox FK Nova 27

This is a description of a prescription medication called Enoxaparin Sodium Injection. It comes in syringes with an automatic safety device for subcutaneous injection. Each syringe contains 60mg of Enoxaparin derived from porcine intestinal mucosa. It is used for subcutaneous injection, and the recommended dosage and instructions for use can be found in the package insert. The safety system can only be activated once the syringe is empty, and activation must be done only after removing the needle from the patient's skin. The syringes should be disposed of in sharps containers after use.*

Enox FK Nova 28

Enox FK Nova 28

This is a description of a medicine called Enoxaparin Sodium. It is an injection administered through a subcutaneous route. The medicine is contained in single-dose syringes with an automatic safety device. The package contains ten 0.8 mL syringes. The recommended dosage and administration are indicated in the package insert. The medicine is derived from porcine intestinal mucosa in Water for Injection. The package contains warning information and directions for use. The temperature for storage is between 15-30°C (59-86°F). It is to be disposed of properly in the nearest sharps container. It is manufactured by Fresenius Kabl USA, LLC, and the trademark is Novation, LLC.*

Enox FK Nova 29

Enox FK Nova 29

Enoxaparin Sodium Injection is a medication that is delivered through injection. Each syringe contains 100 mg of Enoxaparin Sodium. The medication is administered subcutaneously, and each syringe has an automatic safety device. The package comes with ten 1 mL syringes. The dosage instructions are given in the package insert. It is vital to follow the instructions for administration very carefully. This medication must be kept out of reach of children and stored at room temperature. It is manufactured for Fresenius Kabi USA, LLC, in Singapore. Note that the text contains instructions on the use of the automatic safety device, which should be activated only after injecting the prescribed dose.*

Enox FK Nova 30

Enox FK Nova 30

Enoxaparin Sodium Injection is a prescription medication containing 10 mg enoxaparin sodium derived from porcine intestinal mucosa, with dosing instructions for subcutaneous or intravenous injection. The vial contains 1.5 mg benzyl alcohol and should be stored at 25°C. It is manufactured for Fresenius Kabi USA and registered under the trademark NOVAPLUS by Novation LLC, with the NDC code 63323-539-13.*

Enox FK Nova 31

Enox FK Nova 31

This is a description of Enoxaparin Sodium Injection, a medication that is administered through subcutaneous injection using a single dose syringe with automatic safety device. The syringes contain 120 mg of Enoxaparin Sodium Injection that is derived from porcine intestinal mucosa in Water for Injection. The package insert provides directions for use, including dosage information, and administration. The safety system of the syringe can only be activated once the syringe has been emptied, and activation should happen after removing the needle from the patient's skin. The text also provides instructions on how to inject the medicine, and how to dispose of the syringe safely. This medicine should be stored at a temperature of 15-30°C (59-86°F) and is available as ten 0.8 mL syringes with automatic safety devices.*

Enox FK Nova 32

Enox FK Nova 32

Enoxaparin Sodium Injection is a medication used for subcutaneous injection in patients for the treatment of various conditions. It comes in the form of ten single-dose syringes that have an automatic safety device. Each syringe contains 150mg of Enoxaparin Sodium Injection derived from porcine intestinal mucosa. Dosage information is provided in the package insert. The manufacturers advise keeping the medication out of reach of children and storing it within a temperature range of 15-30°C. The syringes should be disposed of in a sharps container after use. The automatic safety device should be activated after the injection to prevent injury.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.